Dialysis

Humana and Strive Health Announce Expansion of Holistic, Patient-Centered Care for People with Kidney Disease

Retrieved on: 
Tuesday, March 5, 2024
General Health, Other Health, Health, Managed Care, Health Insurance, Chronic kidney disease, Multimedia, HMO, PPO, Kidney disease, Quality of life, Dialysis, Entrepreneurship, Humana, Medicare, Patient, Partnership

Leading health and well-being company Humana Inc. (NYSE: HUM) and kidney care provider Strive Health have announced a new value-based care multi-state agreement for most Humana Medicare Advantage HMO and PPO plan members who live with kidney disease.

Key Points: 
  • Leading health and well-being company Humana Inc. (NYSE: HUM) and kidney care provider Strive Health have announced a new value-based care multi-state agreement for most Humana Medicare Advantage HMO and PPO plan members who live with kidney disease.
  • With this agreement, members with chronic kidney disease and end-stage kidney disease in Indiana, Illinois, Kentucky, Michigan and northwest North Carolina now have access to Strive’s value-based kidney care.
  • “Humana is committed to providing our members with evidence-based, multi-specialty kidney care,” said Jim Stodola, Humana Vice President of Trend Management.
  • “Our expanded partnership will allow us to serve thousands of patients through a value-based approach to kidney care and further our mission to deliver compassionate kidney care through data-driven insights, high-touch care and prevention.”
    The new value-based care agreement builds on an existing Humana and Strive relationship, which began in Indiana and Kentucky in 2020.

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Community Health Systems, Inc. (CYH)

Retrieved on: 
Thursday, February 29, 2024
Class Action Lawsuit, Professional Services, Legal, Community health, CYH, Annual report, News, Dialysis, Manager, Community Health Systems, Community, Justice, Private investigator

The law firm of Kirby McInerney LLP is investigating potential claims against Community Health Systems, Inc. (“Community Health” or the “Company”) (NASDAQ: CYH ).

Key Points: 
  • The law firm of Kirby McInerney LLP is investigating potential claims against Community Health Systems, Inc. (“Community Health” or the “Company”) (NASDAQ: CYH ).
  • The investigation concerns whether Community Health and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On February 21, 2024, Community Health disclosed that it was under investigation by the Department of Justice in its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 filed with the SEC.
  • Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Community Health Systems, Inc. (CYH) on Behalf of Investors

Retrieved on: 
Thursday, February 29, 2024
Class Action Lawsuit, Professional Services, Legal, Community health, GPM, CYH, Person, News, Dialysis, Manager, Community Health Systems, Community, Justice

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Community Health Systems, Inc. (“Community Health” or the “Company”) (NYSE: CYH ) investors concerning the Company’s possible violations of the federal securities laws.

Key Points: 
  • Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Community Health Systems, Inc. (“Community Health” or the “Company”) (NYSE: CYH ) investors concerning the Company’s possible violations of the federal securities laws.
  • If you suffered a loss on your Community Health investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at www.glancylaw.com/cases/Community-Health-Systems-Inc-1/ .
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • Whistleblower Notice: Persons with non-public information regarding Community Health should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Community Health Systems, Inc. (CYH) on Behalf of Investors

Retrieved on: 
Wednesday, February 28, 2024
Class Action Lawsuit, Professional Services, Legal, Community health, Manager, CYH, Community Health Systems, Dialysis, News, Community, Suite, Justice, Telephone

Law Offices of Howard G. Smith announces an investigation on behalf of Community Health Systems, Inc. (“Community Health” or the “Company”) (NYSE: CYH ) investors concerning the Company’s possible violations of federal securities laws.

Key Points: 
  • Law Offices of Howard G. Smith announces an investigation on behalf of Community Health Systems, Inc. (“Community Health” or the “Company”) (NYSE: CYH ) investors concerning the Company’s possible violations of federal securities laws.
  • If you purchased Community Health securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to [email protected] , or visit our website at www.howardsmithlaw.com .
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
  • View source version on businesswire.com: https://www.businesswire.com/news/home/20240228709195/en/

The Law Offices of Frank R. Cruz Announces Investigation of Community Health Systems, Inc. (CYH) on Behalf of Investors

Retrieved on: 
Wednesday, February 28, 2024
Professional Services, Class Action Lawsuit, Community health, Manager, CYH, Community Health Systems, Dialysis, News, Community, Suite, Justice, Law

The Law Offices of Frank R. Cruz announces an investigation of Community Health Systems, Inc. (“Community Health” or the “Company”) (NYSE: CYH ) on behalf of investors concerning the Company’s possible violations of federal securities laws.

Key Points: 
  • The Law Offices of Frank R. Cruz announces an investigation of Community Health Systems, Inc. (“Community Health” or the “Company”) (NYSE: CYH ) on behalf of investors concerning the Company’s possible violations of federal securities laws.
  • If you are a shareholder who suffered a loss, click here to participate.
  • If you inquire by email please include your mailing address, telephone number, and number of shares purchased.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

New Dassault Systèmes Virtual Twin Experience Helps Protect Vulnerable Patients and Educate Caregivers at Saint-Louis Hospital AP-HP in Paris

Retrieved on: 
Tuesday, February 27, 2024
Manufacturing, Biometrics, Other Health, Other Professional Services, Thought Leadership, Telemedicine, Virtual Medicine, Medical Devices, Hospitals, Electronic Design Automation, Professional Services, Data Management, Technology, Biotechnology, Health, Apps, Applications, Health Technology, Engineering, Training, Education, Hospital, Atmosphere, SIMULIA, PLM, Dassault Group, Multimedia, Physician, Dialysis, 3D, Product lifecycle, Immunodeficiency, Learning, Virus, Nursing, Control, Patient, Infection, Ventilation, Healthcare industry, Mask, Euronext Paris, Partnership

To create this virtual twin, Dassault Systèmes worked with building blueprints, coupled with a 3D scan of the room made on site using its HomeByMe mobile application to check for any discrepancies.

Key Points: 
  • To create this virtual twin, Dassault Systèmes worked with building blueprints, coupled with a 3D scan of the room made on site using its HomeByMe mobile application to check for any discrepancies.
  • Equipped with this information, Dassault Systèmes developed the augmented reality experience enabling the stakeholders to view the virtual simulations within the real-life setting.
  • “Dassault Systèmes had already worked on projects at other hospitals in Paris and understood our mission to offer the highest level of care.
  • “This incredibly innovative educational experience made our health professionals more aware of respiratory cross-transmission risks in the hospital.

Outset Medical to Present at the 44th Annual TD Cowen Health Care Conference

Retrieved on: 
Monday, February 26, 2024
Diabetes, Health, Medical Devices, Dialysis, Medicine

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will present at the 44th annual TD Cowen Health Care conference on Tuesday, March 5, 2024, at 1:30 p.m. Eastern time.

Key Points: 
  • Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will present at the 44th annual TD Cowen Health Care conference on Tuesday, March 5, 2024, at 1:30 p.m. Eastern time.

Broadstone Net Lease Announces 2023 Results and its Healthcare Portfolio Simplification Strategy

Retrieved on: 
Wednesday, February 21, 2024
Professional Services, Other Construction & Property, Commercial Building & Real Estate, Finance, Construction & Property, REIT, OP, Investment, Dialysis, Sale, Tenant, BNL, MOB, Risk, ABR, Line of credit, Public expenditure, Plasma, Environment, Commercial property

Broadstone Net Lease, Inc. (NYSE: BNL) (“BNL”, the “Company”, “we”, “our”, or “us”), today announced its operating results for the year and quarter ended December 31, 2023, and its healthcare portfolio simplification strategy.

Key Points: 
  • Broadstone Net Lease, Inc. (NYSE: BNL) (“BNL”, the “Company”, “we”, “our”, or “us”), today announced its operating results for the year and quarter ended December 31, 2023, and its healthcare portfolio simplification strategy.
  • See Healthcare Portfolio Simplification Strategy section below for additional information.
  • Refer to our fourth quarter 2023 investor presentation for more detailed information regarding our healthcare portfolio simplification strategy.
  • Our healthcare portfolio simplification strategy is an extension of our focus on portfolio quality and evolution, which we believe will result in meaningful value creation for investors.”

Outset Medical Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Wednesday, February 21, 2024
Diabetes, Health Technology, Health, Medical Devices, Medicine, Investment, Marketing, Dialysis, Growth, S&M, GAAP, Webcast, Patient, G&A, Appendix, Bank statement, Research, Video game

Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the fourth quarter and full year ended December 31, 2023.
  • Fourth quarter gross margin reached 25.3% (26.7% on a non-GAAP basis) compared to 16.5% (17.1% on a non-GAAP basis) in the fourth quarter of 2022.
  • Product revenue was $22.9 million, representing a decrease of 13.2% compared to $26.4 million in the fourth quarter of 2022.
  • Product gross profit was $8.3 million, compared to $4.3 million of product gross profit in the fourth quarter of 2022.

New CDC Respiratory Guidance Ignores Kidney Patient Concerns

Retrieved on: 
Thursday, March 7, 2024
Hospital, Dialysis, Infection, Kidney, HHS, Vaccine, Health, History, Organization, Kidney disease, Patient, Mortality, Kidney failure, Diabetes, Chronic kidney disease, Social media, Ageing, Loneliness, Transplant, Veterans' affairs, Emergency department, CDC, ESRD, Omicron, CDRH, COVID-19 vaccine, CKD, Safety, Hypertension, Congress, Disease, Monovalence, FDA, Friends, Food, Immunodeficiency, Risk, COVID-19, Read, Medicare, FMLA, Death, Control, COVID, Policy, Device, Science, Failure, Public

WASHINGTON, March 7, 2024 /PRNewswire/ -- Today, the American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, issued an Official Statement (appears below) in response to the Center for Disease Prevention and Control's (CDC) new Respiratory Virus Guidance, publicly announced on March 1, 2024. The CDC announcement occurred on the first day of National Kidney Month. March traditionally unites kidney stakeholders and people of goodwill in efforts to raise awareness of kidney diseases, address ongoing unmet patient needs, and advocate for removal of federal regulatory and payment barriers that impede access to, and development of, new kidney diagnostics, drugs, and devices.

Key Points: 
  • Mortality rates among kidney patients occurred at historic levels at the start of the COVID pandemic, devastated the kidney patient community and families, and this community's ongoing risks remain a strategic concern among patient advocates and allied kidney professionals.
  • AAKP also raised kidney patient health and safety concerns to CDC officials in stakeholder briefings prior to the March 1, 2024, CDC Respiratory Virus Guidance announcement.
  • The American Association of Kidney Patients (AAKP), the nation's largest and oldest independent kidney patient organization in the nation, is deeply concerned about the Center for Disease Prevention Control's (CDC) Respiratory Virus Guidelines, including for COVID, announced on March 1, 2024.
  • https://www.cdc.gov/mmwr/volumes/73/wr/mm7308a5.htm
    Since 1969, The American Association of Kidney Patients has been a patient-led organization driving policy discussions on kidney patient care choice and medical innovation.